Research and Development

Showing 15 posts of 9573 posts found.

robertson_1

Redx Pharma appoints Dr Jane Robertson as Chief Medical Officer

October 29, 2020 Research and Development

Redx Pharma has announced the appointment of Dr Jane Robertson as its new Chief Medical Officer at the company. Robertson …
vaccination-1215279_960_720

GSK and Sanofi promise 200m COVID-19 vaccines to international COVAX initiative

October 28, 2020 Manufacturing and Production, Research and Development COVAX, COVID-19, GSK, Sanofi

Sanofi and GSK have committed 200 million doses of their adjuvanted recombinant protein-based COVID-19 vaccine to the COVAX Facility, a …

Novartis collaborates with Molecular Partners to develop therapies to use against COVID-19

October 28, 2020 Research and Development

Novartis and Molecular Partners AG have announced that they will develop, commercialise and manufacture Molecular’s anti-COVID-19 DARPin programme, which consists …
lilly_building_with_american_flag_web

US reserves 300,000 doses of Lilly’s COVID-19 treatment in $375 million deal

October 28, 2020 Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Eli Lilly, US, pharma

The US Government has signed a $375 million deal with Eli Lilly to buy 300,000 700mg doses of bamlanivimab, its …

80% of COVID-19 patients in study were vitamin D-deficient

October 28, 2020 Research and Development

New research has found that over 80% of COVID-19 patients in a recent study had a vitamin D deficiency.  The …
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

October 28, 2020 Research and Development

The coronavirus news this week focuses on clinical trials testing potential vaccines, with the University of Oxford and AstraZeneca stating …
astrazeneca-sign

AstraZeneca’s COVID-19 vaccine generates immune response in both old and young participants

October 26, 2020 Research and Development, Sales and Marketing AstraZeneca, COVID-19, University of Oxford, Vaccine

AstraZeneca’s much-hyped COVID-19 vaccine candidate, AZD1222, currently in development in partnership with the University of Oxford, has shown promising immune …
me_and_calcin_at_aquarium_usa

Patient Experience: Living with Timothy syndrome

October 26, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Timoty syndrome, feature, patient experience, rare disease

Thirteen-year-old Calvin Muir lives with the ultra-rare genetic condition Timothy syndrome. Like many parents of rare disease patients, his mother …
generic-social-banners_v3_veeva-generic

Three Ways to Speed Your GxP Validation without Risk

October 23, 2020 Medical Communications, Research and Development

Computer system validation can often take months to complete. It typically involves infrastructure qualification (IQ), operational qualification (OQ), and performance …
gilead-sciences

Gilead’s Biktarvy proves non-inferior to standard care for HIV in Black and African American patients

October 22, 2020 Research and Development Biktarvy, Gilead, HIV, pharma

Gilead has revealed promising new Phase 3 data reinforcing the non-inferiority of Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg) compared to …
800px-european_commission_flags

The European Medicines Agency recommends 10 medicines for approval in October meeting

October 22, 2020 Research and Development

The EMA has recommended marketing authorisation for ten medicines and has also suggested ten label extensions.  The agency’s Committee for …
800px-tb_researchers

Patient dies on AstraZeneca COVID-19 vaccine trial, but didn’t receive vaccine dose

October 22, 2020 Research and Development

The University of Oxford and AstraZeneca say they will continue their coronavirus vaccine clinical trials after a volunteer had died …
800px-oxycontin_branded_oxycodone_10mg_oc_side_2

Purdue Pharma pleads guilty to opioid charges in $8bn settlement with US Department of Justice

October 22, 2020 Research and Development

Purdue Pharma has pleaded guilty to criminal charges filed due to its role in America’s opioid crisis and will pay …
vaccination-1215279_960_720

Spain secures 31.6 million doses of AstraZeneca’s COVID-19 vaccine

October 21, 2020 Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Spain, Vaccine

AstraZeneca continues to forge agreements with national governments to deliver its vaccine against COVID-19, with Spain becoming the latest country …
The Gateway to Local Adoption Series

Latest content